“…Bacterial infectious diseases represent a serious threat to human health, posing a major challenge for global healthcare because of the rapid emergence of antibiotic-resistant bacterial strains. , Bacteria employ multiple tolerance mechanisms against antibiotics, resulting in suboptimal drug concentrations at infection sites. , This necessitates higher antibiotic doses for effective treatment, consequently exposing healthy cells to increased risk. − Over the past decades, substantial efforts have been directed toward developing antibiotic alternatives, such as metal-based nanoparticles, antimicrobial peptides, , and various antimicrobial polymers, − aiming to combat antibiotic-resistant pathogenic strains. − Another obstacle for treatment of bacterial infection is that up to 80% of infections are associated with bacterial biofilm formation . Biofilms consist of highly organized communities of cells protected by an extracellular polymer matrix (EPS). , This EPS severely hinders the diffusion of antimicrobials into the deep layers of biofilms, resulting in significantly reduced antimicrobial activity compared to planktonic bacteria. , Therefore, the next generation of antimicrobials must possess the ability to penetrate biofilms effectively and exhibit a high potency against bacteria within a biofilm.…”